Bank of Nova Scotia
AGN

Bank of Nova Scotia’s Allergan plc AGN Stock Holding History

Bank of Nova Scotia’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,531,017
Closed -$448M – 1081
2020
Q1 		$448M Buy
2,531,017
+436,870
+21% +$82.3M 1.54% 13
2019
Q4 		$400M Buy
2,094,147
+913,089
+77% +$165M 0.97% 18
2019
Q3 		$199M Buy
1,181,058
+1,100,284
+1,362% +$179M 0.59% 42
2019
Q2 		$13.5M Sell
80,774
-11,283
-12% -$1.56M 0.06% 262
2019
Q1 		$13.5M Buy
92,057
+23,905
+35% +$3.47M 0.05% 278
2018
Q4 		$9.11M Sell
68,152
-4,590
-6% -$752K 0.04% 291
2018
Q3 		$13.9M Buy
72,742
+35,231
+94% +$6.47M 0.06% 253
2018
Q2 		$6.25M Sell
37,511
-6,665
-15% -$1.07M 0.03% 322
2018
Q1 		$7.43M Sell
44,176
-8,392
-16% -$1.41M 0.04% 330
2017
Q4 		$8.6M Sell
52,568
-15,934
-23% -$2.86M 0.04% 334
2017
Q3 		$14M Sell
68,502
-77,760
-53% -$18.1M 0.08% 206
2017
Q2 		$35.6M Sell
146,262
-898
-0.6% -$211K 0.19% 110
2017
Q1 		$35.2M Buy
147,160
+65,616
+80% +$15.3M 0.15% 125
2016
Q4 		$17.1M Buy
81,544
+23,505
+40% +$4.87M 0.09% 152
2016
Q3 		$13.4M Buy
58,039
+50,150
+636% +$12.3M 0.08% 134
2016
Q2 		$1.82M Buy
7,889
+450
+6% +$104K 0.01% 298
2016
Q1 		$1.99M Buy
7,439
+68
+0.9% +$19.5K 0.01% 300
2015
Q4 		$2.3M Buy
7,371
+40
+0.5% +$11.9K 0.01% 324
2015
Q3 		$1.99M Buy
7,331
+320
+5% +$98.3K 0.01% 263
2015
Q2 		$2.13M Buy
7,011
+221
+3% +$65.9K 0.01% 225
2015
Q1 		$2.02M Buy
6,790
+2,318
+52% +$661K 0.01% 230
2014
Q4 		$1.15M Buy
4,472
+57
+1% +$14.2K ﹤0.01% 265
2014
Q3 		$1.06M Buy
4,415
+1,675
+61% +$375K ﹤0.01% 278
2014
Q2 		$611K Buy
2,740
+123
+5% +$25.5K ﹤0.01% 330
2014
Q1 		$539K Buy
2,617
+273
+12% +$54.1K ﹤0.01% 368
2013
Q4 		$394K Buy
2,344
+539
+30% +$84.3K ﹤0.01% 417
2013
Q3 		$260K Sell
1,805
-5
-0.3% -$666 ﹤0.01% 446
2013
Q2 		$229K Buy
+1,810
New +$205K ﹤0.01% 439

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Bank of Nova Scotia's AGN Position: Q2 2020 in Review

Bank of Nova Scotia sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,531,017 shares — an estimated $448M sold.

Bank of Nova Scotia first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $448M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Bank of Nova Scotia reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Bank of Nova Scotia sold 2,531,017 Allergan plc shares in Q2 2020, an estimated $448M.
  • Bank of Nova Scotia first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Bank of Nova Scotia's Allergan plc position peaked at $448M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Bank of Nova Scotia's 13F filing for Q2 2020, filed 11 Aug 2020.